Radiopharmaceuticals: new antimicrobial agents
Authors:
- Peter H. NibberingPNPeter H. Nibbering
- Mick M. WellingMick M. Welling
- Ernest K.J. PauwelsEPErnest K.J. Pauwels
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 21 (2) , 70-73
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- β-Defensin 1 Contributes to Pulmonary Innate Immunity in MiceInfection and Immunity, 2002
- Activity of Novispirin G10 againstPseudomonas aeruginosaIn Vitro and in Infected BurnsAntimicrobial Agents and Chemotherapy, 2002
- Retrocyclin: A primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1Proceedings of the National Academy of Sciences, 2002
- Defensins of vertebrate animalsCurrent Opinion in Immunology, 2002
- Antimicrobial peptides of multicellular organismsNature, 2002
- Cationic peptides: effectors in innate immunity and novel antimicrobialsThe Lancet Infectious Diseases, 2001
- In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 2001
- Antimycobacterial Agent Based on mRNA Encoding Human β-Defensin 2 Enables Primary Macrophages To Restrict Growth ofMycobacterium tuberculosisInfection and Immunity, 2001
- Candidacidal Activities of Human Lactoferrin Peptides Derived from the N TerminusAntimicrobial Agents and Chemotherapy, 2000
- Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation.Journal of Clinical Investigation, 1998